EUVIMEDOpdag EUVIMED
Übersichtsarbeit

Osteoradionecrosis treatment in head and neck cancer patients: An overview of systematic reviews

Gabriella Torres Schroter, Renata Maria Mamprin Stopiglia, Giovanna Lopes Carvalho iD, Susana Morimoto, Maria Emília Mota, Fábio Abreu Alves iD, Graziella Chagas Jaguar, Maria Stella Moreira iD

Special Care in Dentistry · 2024

DOI: 10.1111/scd.12910 ↗

At a glance

Übersichtsarbeit in Special Care in Dentistry, 2024. Written by Gabriella Torres Schroter and 7 co-authors. Institution: Department of Stomatology, School of Dentistry, University of São Paulo (USP), São Paulo, Brazil. Major MEDLINE topics: Head and Neck Neoplasms, Hyperbaric Oxygenation, Osteoradionecrosis, Pentoxifylline. Cited 8 times so far (Crossref); 29 references. Funded by: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Aims

Evaluate the existing evidence of osteoradionecrosis (ORN) treatment in adults with head and neck cancer, the methodological quality and the evidence grade within systematic reviews (SRs).

Methods

An extensive systematic literature search of SRs that addressed ORN in head and neck cancer patients was conducted with screening of eligible studies, data extraction, methodological (AMSTAR 2) and evidence quality assessment (GRADE) of the SRs by independent and calibrated authors.

Results

A total of six SRs were enrolled. Based primarily on studies from the 1990s, there is critically low‐ or moderate‐quality evidence that hyperbaric oxygen therapy (HBO) improves ORN healing. From 2005 onward, evidence has been discovered in relation to treatment with pentoxifylline and tocopherol (PENTO). The SRs indicate that the management of ORN with PENTO appears to be promising. The greatest rates of healing are seen in mild and moderate stages of ORN. However, the quality of evidence regarding PENTO, surgery and other treatments remains critically low.

Conclusion

There is no standardized protocol to treat ORN. PENTO appears to be the most promising conservative treatment; however, the current level of evidence regarding PENTO is still critically low. More robust clinical studies are needed to establish the best treatment for ORN.

Subjects

MeSH terms (MEDLINE)

Head and Neck NeoplasmsHyperbaric OxygenationOsteoradionecrosisPentoxifyllineTocopherolsHumansSystematic Reviews as Topic

Author keywords

head and neck cancerhyperbaric oxygenationosteoradionecrosisoverviewpentoxifyllinesystematic reviews

Substances

PentoxifyllineTocopherols

Authors and institutions

  • Department of Stomatology, School of Dentistry, University of São Paulo (USP), São Paulo, Brazil.
  • Department of Stomatology, AC Camargo Cancer Center, São Paulo, Brazil.
  • Postgraduate Program in Dentistry, Ibirapuera University, São Paulo, Brazil.

ORCID profiles: Giovanna Lopes Carvalho, Fábio Abreu Alves, Maria Stella Moreira

Funding

  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

Cite

APA

Schroter, G. T., Stopiglia, R. M. M., Carvalho, G. L., Morimoto, S., Mota, M. E., Alves, F. A., Jaguar, G. C., & Moreira, M. S. (2024). Osteoradionecrosis treatment in head and neck cancer patients: An overview of systematic reviews. Special Care in Dentistry. https://doi.org/10.1111/scd.12910

Vancouver

Schroter GT, Stopiglia RMM, Carvalho GL, Morimoto S, Mota ME, Alves FA, et al. Osteoradionecrosis treatment in head and neck cancer patients: An overview of systematic reviews. Special Care in Dentistry. 2024. doi:10.1111/scd.12910

BibTeX
@article{Schroter2024,
  author = {Schroter, Gabriella Torres and Stopiglia, Renata Maria Mamprin and Carvalho, Giovanna Lopes and Morimoto, Susana and Mota, Maria Emília and Alves, Fábio Abreu and Jaguar, Graziella Chagas and Moreira, Maria Stella},
  title = {Osteoradionecrosis treatment in head and neck cancer patients: An overview of systematic reviews},
  journal = {Special Care in Dentistry},
  year = {2024},
  doi = {10.1111/scd.12910}
}
Start for free →